Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc.
1:16-cv-11091
Overview
Parties
Defendant
Collegium Pharmaceutical, Inc. Operating Company
Represented By
0 Attorneys ListedPurdue Pharma, L.P. NPE (University / Research)
Represented By
1 Attorneys ListedJones Day (Bos)
Jones Day (Bos), 100 High Street
Court & Judges
Court
District Court, D. Massachusetts (mad)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 9,155,717 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,511,065 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2017011975 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,022,369 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2019004652 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 31,053,501 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 7,157,103 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 7,727,557 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,652,497 B2 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9155717
Pharmaceutical formulation containing irritant
|
Filed: 2014-01-07
Issued: 2015-10-13
|
Active (7.1 yrs remaining)
Expires: 2034-01-07
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
1
Dispositive
0
Granted
0
Denied
0
Pending / Review
0
Motions by Category
Key Dispositive Motions & Rulings